rs58036849

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001077350.3(NPRL3):​c.1486G>A​(p.Ala496Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00209 in 1,613,600 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A496A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 28 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 30 hom. )

Consequence

NPRL3
NM_001077350.3 missense

Scores

3
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.15

Publications

0 publications found
Variant links:
Genes affected
NPRL3 (HGNC:14124): (NPR3 like, GATOR1 complex subunit) Contributes to GTPase activator activity. Involved in cellular response to amino acid starvation and negative regulation of TOR signaling. Located in lysosomal membrane. Part of GATOR1 complex. Implicated in focal epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
NPRL3 Gene-Disease associations (from GenCC):
  • focal epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial focal, with variable foci 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial focal epilepsy with variable foci
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0042395294).
BP6
Variant 16-88756-C-T is Benign according to our data. Variant chr16-88756-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445596.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0104 (1583/152320) while in subpopulation AFR AF = 0.0354 (1471/41568). AF 95% confidence interval is 0.0339. There are 28 homozygotes in GnomAd4. There are 769 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1583 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPRL3NM_001077350.3 linkc.1486G>A p.Ala496Thr missense_variant Exon 13 of 14 ENST00000611875.5 NP_001070818.1 Q12980Q9BTE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPRL3ENST00000611875.5 linkc.1486G>A p.Ala496Thr missense_variant Exon 13 of 14 5 NM_001077350.3 ENSP00000478273.1 Q12980

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1574
AN:
152202
Hom.:
28
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0353
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00451
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0101
GnomAD2 exomes
AF:
0.00266
AC:
634
AN:
238788
AF XY:
0.00212
show subpopulations
Gnomad AFR exome
AF:
0.0366
Gnomad AMR exome
AF:
0.00183
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000249
Gnomad OTH exome
AF:
0.000863
GnomAD4 exome
AF:
0.00123
AC:
1797
AN:
1461280
Hom.:
30
Cov.:
31
AF XY:
0.00112
AC XY:
817
AN XY:
726884
show subpopulations
African (AFR)
AF:
0.0384
AC:
1287
AN:
33474
American (AMR)
AF:
0.00188
AC:
84
AN:
44664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39688
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53348
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
0.000240
AC:
267
AN:
1111718
Other (OTH)
AF:
0.00215
AC:
130
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
93
186
279
372
465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1583
AN:
152320
Hom.:
28
Cov.:
33
AF XY:
0.0103
AC XY:
769
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0354
AC:
1471
AN:
41568
American (AMR)
AF:
0.00451
AC:
69
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68028
Other (OTH)
AF:
0.00995
AC:
21
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
84
168
252
336
420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00818
Hom.:
18
Bravo
AF:
0.0124
ESP6500AA
AF:
0.0332
AC:
145
ESP6500EA
AF:
0.000234
AC:
2
ExAC
AF:
0.00319
AC:
386
Asia WGS
AF:
0.00173
AC:
6
AN:
3474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 05, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed in large population cohorts (Lek et al., 2016) In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function Has not been previously published as pathogenic or benign to our knowledge Observed in heterozygous state in multiple clinically unaffected adult relatives of individuals referred for genetic testing at GeneDx, suggesting the variant is benign -

Epilepsy, familial focal, with variable foci 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;.;T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.00079
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.89
D;D;.
MetaRNN
Benign
0.0042
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
4.1
PrimateAI
Benign
0.41
T
REVEL
Benign
0.060
Sift4G
Benign
0.56
T;T;T
Polyphen
0.0010
B;.;B
Vest4
0.28
MVP
0.39
MPC
0.24
ClinPred
0.0094
T
GERP RS
4.5
Varity_R
0.11
gMVP
0.31
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58036849; hg19: chr16-138755; API